BiotechTube
Fusix Biotech

Fusix Biotech

Munich, Germany· Est.
fusixbiotech.de
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Fusix Biotech is a private, preclinical-stage biotech developing novel oncolytic virus therapies for cancer. Its core asset is the InFUSE platform, which aims to combine potent tumor cell killing via fusogenic cell death with a favorable safety profile and systemic intravenous delivery. The company is led by its four scientific founders, is supported by academic partnerships and pre-seed grants, and is currently focused on advancing its platform through preclinical proof-of-concept and manufacturing setup.

Oncology

Technology Platform

Proprietary InFUSE™ oncolytic virus platform designed for systemic (IV) delivery, combining direct tumor cell killing via fusogenic cell death with potent immune-stimulatory properties and a claimed excellent safety profile.

Opportunities

The oncolytic virus market is growing, with significant unmet need for effective, systemically delivered immunotherapies for solid tumors.
Fusix's InFUSE platform, with its focus on fusogenic cell death and IV delivery, could address cold tumors and metastatic disease, positioning it for potential partnerships or leadership in a niche segment.

Risk Factors

High preclinical failure risk associated with translating platform efficacy and safety to humans.
The company faces immediate financing risk to fund costly clinical trials and significant competition from other OV and immunotherapy developers with greater resources.

Competitive Landscape

Fusix competes in the oncolytic virus space against companies like Amgen (T-VEC), DNAtrix, and Turnstone Biologics, as well as numerous biotechs developing next-generation OVs. Its key differentiators are the fusogenic cell death mechanism and systemic delivery focus, but it faces rivals with more advanced clinical programs and substantial funding.

More companies in Immunotherapy / Immuno-Oncology →More companies in Germany →